Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Circ Res. Author manuscript; available in PMC 2010 November 20.
Published in final edited form as:
PMCID: PMC2783176

Complement Dependent Inflammation and Injury in a Murine Model of Brain Dead Donor Hearts



Donor brain death (BD) is an unavoidable occurrence in heart transplantation and results in profound physiologic derangements that render the heart more susceptible to ischemia/reperfusion injury in the recipient, and likely has negative long-term consequences to allograft survival.


We developed a novel mouse model of BD and investigated the role of complement in BD-induced myocardial inflammation and injury.

Methods and Results:

Brain death was induced by inflation of a balloon catheter in the cranial cavity. BD in wild type mice resulted in a significant increase in serum concentrations of the complement activation product C3a, and immunohistochemical analysis of heart sections demonstrated C3 deposition on the vascular endothelium and surrounding myocytes. Following induction of BD in complement (C3) deficient mice, cardiac troponin levels and histological evidence of injury were significantly reduced compared to wt mice. C3 deficiency was also associated with reduced myocardial leukocyte infiltration, and reduced or absent expression of P-selectin, I-CAM-1, V-CAM-1, TNF-α and IL-1β.


These data indicate an important role for complement in BD-induced inflammation and injury and suggest that a complement inhibitory strategy applied to the donor (in addition to the recipient) may provide graft protection.

Keywords: Complement, Brain death, heart transplantation, inflammation, mouse model


Heart transplantation has become a highly successful treatment for end-stage heart disease. Advances in immunosuppression have led to dramatic improvements in first year survival, due largely to better modulation of the alloimmune response. However, despite these improvements, primary graft failure, acute rejection and cardiac allograft vasculopathy are still major limitations to short and long-term survival. The precise mechanisms involved in the development of primary graft failure and chronic rejection are not well understood. Recently, brain death (BD) and ischemia/reperfusion injury (IRI) have been implicated in graft endothelial activation and injury, which in turn have been linked to the pathogenesis of graft dysfunction and chronic rejection 1-3. Clinical studies of renal transplant recipients, and to a lesser extent domino donation in heart transplant recipients, have highlighted the deleterious impact that donor BD has on transplant outcome 4. Recipients receiving allografts from living donors experience fewer rejection episodes, are less susceptible to primary graft failure, and as a consequence survive significantly longer than patients receiving organs from cadaveric sources 2-5. Initially it was proposed that these significant improvements were a result of reduced ischemic times, but recent evidence points towards the effects of donor BD as a stimulating factor in priming the donor organ and rendering it pro-inflammatory 2, 6, 7.

Brain death results in the outpouring of catecholamines, which promotes intense vasoconstriction leading to chaotic swings in blood pressure, hypothermia, coagulopathies, hormone depletion and electrolyte abnormalities. The effects on blood pressure are two fold; an initial hypertensive phase is followed by hypotension resulting in an increase in oxygen supply to the heart. However, the increase is still insufficient to cover the enhanced demand, and results in transient global myocardial ischemia 8, 9. The imbalance in myocardial oxygen demand and supply renders peripheral organs ischemic, which may activate the endothelium by processes similar to that associated with ischemia reperfusion injury (IRI). The mechanism/s of donor organ activation have yet to be fully elucidated but much of the available data from animal studies suggests that imbalances in hormone status, the release of catecholamines, and the systemic up regulation of pro-inflammatory cytokines are responsible for promoting direct organ damage and inflammation. Up regulation of proinflammatory cytokines, such as TNF-α and IL-1β, have been implicated in endothelial activation, along with the expression of adhesion molecules 10, 11.

It is well documented that BD initiates peripheral organ ischemia and that the heart sustains a period of global myocardial ischemia due to the intense physiological changes associated with BD. However, whether BD associated organ injury and “activation” have a similar mechanistic process to IRI is not clear, and while complement has been shown to play a key role in myocardial IRI, its role in the development of donor organ damage and the propagation of a ‘proinflammatory state’ has not been explored.

Materials and Methods

Brain Death Model

Male C57BL/6 wt and C3−/− mice were anesthetized with 10 mg/kg ketamine and 6 mg/kg xylazine by i.p injection. Brain death was induced by a similar basic procedure to that outlined for rats by Pratschke et al., 12, but with modification for use in mice. A burr hole sufficient to insert a 2F Fogarty catheter was drilled into left parasagittal parietal bone. A 2F Fogarty was inserted and mice placed in a supine position for the rest of the experiment. Body temperature was monitored by rectal thermometer, and body temperature maintained using a heated operating table (Harvard Apparatus, Boston, USA) at >36°C. Mouse mean arterial blood pressure (MAP) and heart rate was monitored continuously using physiomax blood pressure monitor (Columbus Instruments, OH, USA). Mice were intubated with a blunt tipped cannula and ventilated with a rodent ventilator with oxygen (Harvard Apparatus, MA; respiration rate, 100/minutes; tidal volume, 8 mL/kg). The catheter was inflated with saline over a 20 minute period until spontaneous respiration ceased, determined by turning the ventilator off for 30 seconds. Brain death was further confirmed by the absence of corneal and pedal reflexes. The total volume of saline required to induce apnea was 80 μl ± 25 μl. Inflation of the catheter induced a characteristic Cushing's Response, during which time the MAP increased, followed later by a recovery of normotensive responses. If we were unable to maintain a MAP of 70 mmHg for a sustained period, experiments were stopped and the animal removed from the study. Timing of the follow-up period began at the point of apnea detection. Confirmation of a brain dead state was carried out every 30 minutes by performing apnea tests and testing corneal and pedal reflexes. No further anesthesia was administered to brain dead animals. Sham controls underwent the same procedure with catheter inserted but without balloon inflation. Supplementary anesthesia was administered as required to sham controls if pedal or corneal reflexes became apparent. After 1 or 3 hours, the heart was removed and dissected into three transverse sections and serum collected. Two sections were immediately frozen in liquid nitrogen and one immersed in formalin for histological analysis. All procedures were approved by the Medical University of South Carolina on Animal Research, in accordance with the National Institute of Health Guide for Care and Use of Laboratory Animals.

Histological Analysis

Formalin fixed sections of heart from controls and brain dead animals were stained with haematoxylin and eosin stains for histological analysis. Sections were assessed for evidence of myocardial damage using the criteria previously described 13. Specifically, features of interstitial and subendocardial hemorrhage and necrosis, contraction band necrosis, paradiscal contraction band lesions, and endothelial swelling were assessed in each heart. The presence of one or more of these features was considered indicative of cardiac damage and deemed positive for this study.

Serum Analysis

Serum analysis for cardiac troponin I (cTnl) (Life Diagnostics, USA), IL-1β and TNF-α (R&D Systems, USA), was performed by ELISA according to manufacturers recommendations. Complement activation was assessed by ELISA for C3a (BD Biosciences, USA).


The presence of complement (C3d, Dakocytomation, USA), IgM (Cappell, USA), neutrophils (GR1, BD Pharmingen, USA), macrophages (mac-3, BD Pharmingen, USA), P-selectin, E-selectin, I-CAM-1, and V-CAM-1 (BD Pharmingen, USA) was assessed by immunohistochemistry. For C3d and IgM analysis was performed on paraffin processed sections with sections receiving microwave antigen retrieval in citrate buffer pH6.0 prior to immunohistochemistry analysis. All antibodies were visualized with a standard avidin biotin detection system (Vector Laboratories, USA) as previously described 14. For further quantification of neutrophils we performed the naphthol AS-D chloroacetate esterase staining technique using a kit from Sigma Aldrich (St Louis, USA) according to the manufacturers instructions. Neutrophil and macrophage numbers were quantified in five random high power fields of each heart section, and quantified by two independent investigators.

RNA Extraction and Real-Time reverse transcription-PCR

Total RNA was extracted from hearts using guanidine isothiocyanate and phenol-chloroform by standard methods 14. Analysis was performed using a My IQ Real-Time detection system (Bio-Rad) using previously described intron-spanning primers specific for ICAM-1 forward 5′-GGCTGGCATTGTTCTCTAA-3′, reverse 5′-TTCAGAGGCAGGAAACAGG-33; VCAM-1 forward 5′-CCCAAACAGAGGCAGAGTGT-3′, reverse 5′-CAGGATTTTGGGAGCTGGTA-3′; E-selectin forward 5′-AGCTACCCATGGAACACGAC-3′, reverse 5′-CGCAAGTTCTCCAGCTGTT-3′; P-selectin forward 5′-ATGCCTGGCTACTGGACACT-3′, reverse 5′-CTTCATCGCACATGAACTGG-3′; TNF forward 5′-ATGCCTGGCTACTGGACACT-3′, reverse 5′-CTTCATCGCACATGAACTGG-3′; and IL-1β forward forward 5′-AGCTACCCATGGAACACGAC-3′, reverse 5′-CGCAAGTTCTCCAGCTGTT-3′. All reactions were performed in triplicate, and the GAPDH gene was used as an internal control.

Statistical Analysis

All data are presented as Mean ± SD. All data were subjected to statistical analysis using Statview Statistical Analysis Software 9 version 5 (SAS Institute Inc.). Statistical analyses of collected data were interpreted by paired Student's t test for comparison of two groups or analysis of variance for the analysis of three or more groups with Newman-Keuls for posthoc analysis. A p value of less than 0.05 was considered significant.


Physiological characteristics of brain death model

Inflation of the intracranial catheter and induction of progressive BD was associated with a sharp chaotic swing to hypertension followed by a period of hypotension before the animal recovers to a normotensive state. Similar responses have been shown to occur in a rat model of progressive BD 12, 13, 15. There was no difference in MAP between wt and C3−/− mice prior to or following BD (Figure 1). Furthermore, analysis of blood pH, O2 and PO2 demonstrated no significant differences in lung function (Supplemental Table I). Thus, any differences between wt and C3 −/− mice in the inflammatory response to BD is unlikely to be caused by physiological differences in the animals response to BD induction. Animals were maintained for a maximum period of 3 hours post BD induction, due largely to the significant technical difficulties in prolonged maintenance of mice in a normotensive state post BD.

Figure 1
Mean arterial blood pressure traces from wild type (A) and C3−/− (B) mice prior to and following induction of BD. Note that the MAP response to BD is similar in each group of animals. Representative images (n =10).

Complement activation

To assess whether BD and the resultant physiological derangements lead to activation of the complement system, we analyzed serum and heart tissue for complement activation products. There was no significant increase in C3a levels at 1 h post surgery in brain dead mice or sham operated controls. However, by 3 h there was a significant increase in C3a levels in brain dead mice (Figure 2A). Complement deposition within the heart following BD was determined by C3d immunohistochemistry. C3d was deposited in hearts from 6 of 10 mice at 1 h post BD, and in 10 of 10 mice by 3 h post BD. There was a low level of nonspecific staining for C3d in areas surrounding myocytes (as evidenced in hearts from C3 −/− mice), but there was a significant increase in the incidence and intensity of C3d staining in hearts from BD animals. Complement was deposited within capillaries, arterioles, and in the area surrounding myocytes (Figure 2B). There was also an increase in incidence and intensity of C3d staining in hearts from brain dead animals ventilated for 3 h compared to animals supported for 1 h (not shown).

Figure 2
Complement activation and myocardial injury following brain death. A: Relative levels of complement activation product C3a in serum from wt brain dead animals and sham operated controls after 3 hours of ventilation support, as determined by ELISA (p < ...

Complement activation has been shown to play a central role in the injury that ensues following ischemia and reperfusion. Recent studies have demonstrated that pre-existing IgM antibodies that recognize so called “ischemic antigens” play a central role in the activation of complement following ischemia and reperfusion 16. To investigate whether IgM antibodies are associated with complement activation following BD, we analyzed heart sections from wt and C3 −/− BD animals for IgM immunoreactivity. IgM binding was seen in both wt and C3−/− brain dead animals, with IgM present on endothelial cells of capillaries and arterioles, with some staining of myocytes (Figure 2C). The pattern and distribution of IgM staining is similar to that seen for C3d, thus supporting the concept that activation of complement after BD occurs via a similar IgM-mediated mechanism that occurs following ischemia and reperfusion.

Myocardial Damage

Serum cardiac troponin 1 (cTnl) is used as a marker of cardiac injury, and clinical studies have shown that raised cTnI levels are associated with poor post transplant outcome. In sham operated wt and C3−/− mice, levels of cTnl were slightly elevated compared to normal controls, but the difference was not significant (data not shown). In brain dead wt mice, cTnl levels were significantly higher than in either wt or C3−/− controls (p=0.03) (Figure 3A). There was no significant increase in cTn1 levels in C3−/− brain dead animals when compared to all other groups.

Figure 3
Cardiac damage following brain death. A. Serum levels of cardiac troponin I in wild type and C3−/− mice following BD. Cardiac troponin levels were analyzed by ELISA in serum samples prepared from 3 hour brain dead animals. The data indicate ...

Heart sections were also assessed for morphological evidence of cardiac damage as denoted by the presence of coagulative necrosis, contraction band necrosis and swelling of the endothelial cells lining intra-myocardial vessels. There was no histological evidence of myocyte damage in any sham-operated animals (either wt or C3−/−). However, in the brain dead groups, 45% of wt animals displayed at least one feature associated with cardiac damage compared to only 13% of C3−/− animals (p=0.004). The most common histological feature seen was endothelial swelling, defined by the presence of enlarged and prominent endothelial nuclei (Figure 3B). To confirm that these morphological features were indeed due to endothelial activation we performed immunohistochemistry studies investigating the expression of endothelial adhesion molecules.

Adhesion Molecule Expression

Numerous studies have highlighted the importance of adhesion molecule expression in donor organ priming post BD. We therefore investigated the association of complement activation with the expression of P-selectin, E-selectin, ICAM-1 and VCAM-1 following BD. Adhesion molecule expression following BD in wt and C3 −/− mice was determined by immunohistochemistry and scored on a scale of 0-3 as previously described17. P-selectin and ICAM1 expression was evident on endothelial cells as early as 1 hour, with no expression seen for E-selectin or VCAM-1. At 3 h post BD, P-selectin and ICAM-1 expression persisted, and VCAM-1 expression could now be detected, but staining for E-selectin remained negative (Figure 4 and Supplemental Table II). In C3 −/− mice, there was no detectable expression of any adhesion molecule at 1 h post BD. At 3 h post BD, only P-selectin and ICAM-1 expression was detected, but at a lower frequency and intensity than that seen in wt animals.

Figure 4
Adhesion molecule protein expression in wild type and C3 −/− mice following brain death. Expression of P-selectin, I-CAM-1, V-CAM and E-selectin was examined in hearts from wt and C3−/− mice at 3 hours following BD. Note ...

We further analyzed the effects of complement on the expression of adhesion molecule transcripts by qRT-PCR. A significant increase in all mRNA levels was noted in wt and C3−/− brain dead animals compared to sham controls. The expression E-selectin and V-CAM was significantly increased in wt versus C3−/− animals (p<0.02) (Figure 5A). Transcript expression of P-selectin and I-CAM mRNA was not statistically different between the groups, even though protein expression of these two adhesion molecules appeared to be increased.

Figure 5
Transcript levels of adhesion molecules and cytokines in wild type and C3−/− mice following brain death. mRNA levels were determined in heart samples isolated from mice 3 hours post BD by quantitative RT-PCR. A: Adhesion molecule transcript ...

Pro-Inflammatory Status

To further investigate whether complement plays a role in the propagation of a ‘pro-inflammatory’ state, we quantified serum protein and tissue mRNA levels of TNF-α and IL-1β by ELISA and qRT-PCR. TNF-α and IL-1β have both been implicated in the development of endothelial activation and adhesion molecule expression. There was no significant difference in serum protein levels of TNFa or IL-1b in either wt or C3−/− mice after BD compared to sham controls (data not shown). However, qRT-PCR analysis revealed significantly reduced tissue transcription of both TNF-α and IL-1β in C3−/− mice compared to wt mice at 3 hours post BD (p<0.02) (Figure 5B).

Cellular Infiltration

Complement activation products C3a and C5a, as well as adhesion molecule expression, play important roles in the recruitment of immune cells to sites of inflammation. Therefore, we investigated inflammatory cell infiltration in brain dead animals. Neutrophils were present in all heart samples, with cells localized to vascular areas and spread between myocytes (Figure 6A&B). Although neutrophils were present in low numbers, there was a significant increase in neutrophil numbers in wt mice at both 1 hour (not shown) and 3 hours (Figure 6C&D) post BD compared to sham mice, as demonstrated by immunohistochemistry staining and enzyme histochemistry techniques. In contrast, the number of infiltrating neutrophils in hearts from C3−/− brain dead mice was not significantly different to the number in C3−/− and wt sham mice (Figure 6C & D).

Figure 6
Neutrophil infiltration in hearts from wt and C3−/− mice following BD. Representative images for wt (A) and C3−/− (B) immunostained with GR-1 for neutrophil localization. C & D. Quantification of neutrophil staining, ...


Donor BD results in physiological derangements which impact the inflammatory nature of the graft, and predisposes the graft to immunological recognition and subsequent graft rejection 18-20. Here we report on the development of a mouse model of BD, which will enable expanded research into inflammatory and immune mechanisms associated with BD due to the availability of gene-deficient mice and the wide availability of mouse-specific reagents. We used the mouse BD model and C3 deficient mice to investigate the role of complement in the propagation of donor organ inflammatory status.

Brain death resulted in complement activation as demonstrated by the deposition of complement in the heart and the presence of complement activation products in the serum, and complement deposition increased with time post BD. The deposition of complement in the mouse heart following BD is in keeping with a previous study that showed increased C3 deposition on the surface of tubular epithelial cells in a brain dead rat donor kidney 15. Following BD, physiological changes in blood pressure and the herniation of the brain stem result in an out-pouring of catecholamines, and these molecules have been shown to induce direct damage to heart myocytes in a canine model of explosive BD 21. However, the pathology of explosive BD is thought to be quite different from the progressive BD studied here, and it is unclear whether myocyte damage in progressive BD is induced directly by catecholamines, impaired coronary perfusion, or by inflammatory mechanisms. Our data support an important role for the latter in that cardiac injury was significantly reduced in C3−/− mice compared to wt mice following BD. Elevated cTnI levels are associated with myocyte damage and have been used as a predictive index of graft outcome post transplantation 22. Complement deficient mice had a significant overall reduction in cTnI levels compared to wt mice following BD. Further C3 deficiency was associated with a reduction in histological evidence of cardiac injury. However, it is important to note that the most common feature of heart injury seen in both groups was endothelial swelling, and that actual myocyte necrosis was rare in wt mice and absent in C3−/− mice. Thus, serum cTnl measured at relatively early time points post BD is associated with discreet injury and not direct myocardial necrosis, at least as could be determined by histological analysis. Similarly, in an earlier study using a canine model, cTnI levels were substantially elevated while myocyte necrosis was rarely seen following progressive BD 21, and there is an absence of histological evidence of myocyte necrosis in rat models of BD 2.

As noted, the most prominent feature of cardiac damage noted post BD was endothelial swelling. This feature is indicative of endothelial activation, a feature that can in part be investigated by analyzing endothelial adhesion molecule expression. Previous studies by Takada et al. 10, 11 demonstrated that P-selectin expression increased post BD and that blockade of this adhesion molecule not only resulted in a reduction in the pro-inflammatory status of the donor organ, but also resulted in improved post transplant survival in models of cardiac and renal transplantation. A deleterious role for expression of P-selectin in the graft is supported by a study showing that transplantation of P-selectin and I-CAM-1 deficient mouse hearts into wt recipients results in a reduction of ischemia reperfusion injury and prolonged graft survival 23. With regard to the current study, the complement activation products C3a, C5a and the MAC have been variously shown to either directly or indirectly induce the expression of P-selectin, E-selectin and ICAM-1 24. Furthermore, we have previously demonstrated that C3 deficiency or inhibition of C3 significantly reduces P-selectin protein expression and transcription in a model of ischemic stroke in-vivo 14. Here we demonstrated that the endothelial expression of adhesion molecules in the mouse heart is associated with BD, and that C3 deficiency reduces adhesion molecule expression. P-selectin and ICAM-1 protein expression was detected 1 hour following BD in wt mice but not in C3−/− mice. At 3 hours post BD, expression of P-selectin and ICAM-1 was detected in C3−/− mice, but at significantly lower levels than in wt mice. VCAM protein expression was detected only in wt mice at either time point following BD. These findings indicate an important role for complement as an effector mechanism in the early expression of adhesion molecules following BD.

Of note, we previously reported that we could find no appreciable difference in adhesion molecule expression in human heart samples from either cadaveric brain dead donors or living domino donors1. However, as we previously hypothesized, the lack of difference in adhesion molecule expression in the human samples may be related to the pro-inflammatory intrathoracic milieu associated with cystic fibrosis in the domino donors and endothelial perturbations associated with cystic fibrosis 25 (living donor hearts are obtained from cystic fibrosis patients undergoing combined heart-lung transplantation). Thus, in the absence of BD, adhesion molecule expression in domino donor hearts may be due to complement-independent mechanisms that are associated with an increased inflammatory burden. We also assessed adhesion molecule mRNA expression by qRT-PCR. We observed significant increases in gene transcription of P-selectin, E-selectin, ICAM-1 and VCAM-1 post BD when compared to baseline controls, but unlike protein levels, only E-selectin and VCAM-1 transcription was significantly lower in C3 −/− mice compared to wt. Constitutively expressed proteins can be readily mobilized from underneath the membrane (such as P-selectin from the Weibel-Palade bodies) in the initial stage. This first phase, which is called Type I activation, does not involve de-novo protein synthesis. The second phase is transcriptionally regulated, a process that takes place 4 or more hours post activation 1, 26. It is therefore likely that the lack of significant differences for certain adhesion molecules may be time dependent. Animals were only maintained for a period of 3 hours post BD induction, due largely to the significant technical difficulties in prolonged maintenance of mice in a normotensive state post BD.

Although we did not see a significant difference in transcription of all of the adhesion molecules analyzed, levels of TNF-α and IL-1β were significantly higher in wt compared to C3−/− mice following BD, indicating a role for complement in the expression of these cytokines. These pro-inflammatory cytokines are associated with graft injury; they are thought to promote intra-graft inflammation and have been shown to have a deleterious effect on graft survival 2, 6, 7, 27. Although TNF-α and IL-1β mRNA levels were elevated following BD, serum concentrations were not significantly different. This is perhaps not surprising since elevation of serum TNF-α and IL-1β occurs in models of explosive BD, but not in models of progressive BD 11.

To determine whether the generation of complement activation products and the expression of adhesion molecules resulting from BD influenced the infiltration of inflammatory cells, we counted neutrophils and macrophages in heart sections isolated from brain dead wt and C3−/− mice. Both cell types were present in wt and C3−/− mice following BD, but there was a significant reduction in the number of infiltrating neutrophils in C3−/− mice compared to wt at 3 hours post BD. This is in contrast to a previous report using a rat model that indicated the effect of BD on inflammatory cell infiltration only manifests following implantation of the donor organ to the recipient2.

A reduction in the number of innate immune cells that are transferred into the recipient may have a significant impact on overall graft immunogenicity. Upon implantation, resident dendritic cells have been shown to migrate to regional lymph nodes, a phenomenon thought to be a prelude to graft recognition and rejection 28. Recent studies have highlighted the important role that macrophages have as antigen presenting cells 28. The current data indicate an increase in donor passenger leukocytes is associated with BD, and this may be a contributing mechanism to the increased the susceptibility of the donor organ to rejection.

In conclusion, we have utilized a mouse model of BD, which provides a tool for expanded research into inflammatory and immune mechanisms associated with BD. We have demonstrated that donor BD leads to activation of the complement system and complement deposition in mouse hearts. The mechanism of complement activation is not defined in the current study, but our data support a hypothesis that activation occurs in response to a transient ischemia of the myocardium induced by BD, which results in the expression of neoantigens that lead to IgM binding and complement activation, as has been shown to occur following myocardial ischemia and reperfusion 16. Finally, studies using C3 deficient mice demonstrated a role for complement in the pro-inflammatory status of the brain dead donor heart as measured by adhesion molecule expression, cytokine expression, inflammatory cell infiltration and cardiac injury. These data suggest that a therapeutic strategy to inhibit complement in the brain dead donor (as well as the recipient) may improve organ quality and graft function.

Supplementary Material


Sources of funding

This study was supported by grants from the NIH (RO1 HL 86562 to ST, and RR 015455 for construction and upgrade of animal facilities) and the American Heart Association (SDG AHA 065100 to CA).

Non-standardAbbreviations and Acronyms

Brain Death
Complement component 3
Cardiac troponin I
Inter-cellular adhesion molecule-1
Immunoglobulin M
Interleukin 1 beta
Ischemia reperfusion Injury
Mean arterial pressure
Messenger ribonucleic acid
Quantitative real-time polymerase chain reaction
Tumor necrosis factor alpha
Vascular cell adhesion molecule-1





1. Stoica SC, Atkinson C, Satchithananda DK, Charman S, Goddard M, Redington AN, Large SR. Endothelial activation in the transplanted human heart from organ retrieval to 3 months after transplantation: an observational study. J Heart Lung Transplant. 2005;24(5):593–601. [PubMed]
2. Wilhelm MJ, Pratschke J, Beato F, Taal M, Kusaka M, Hancock WW, Tilney NL. Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation. 2000;102(19):2426–2433. [PubMed]
3. Cantin B, Kwok BW, Chan MC, Valantine HA, Oyer PE, Robbins RC, Hunt SA. The impact of brain death on survival after heart transplantation: time is of the essence. Transplantation. 2003;76(9):1275–1279. [PubMed]
4. Nicholson ML, Metcalfe MS, White SA, Waller JR, Doughman TM, Horsburgh T, Feehally J, Carr SJ, Veitch PS. A comparison of the results of renal transplantation from non-heart-beating, conventional cadaveric, and living donors. Kidney Int. 2000;58(6):2585–2591. [PubMed]
5. Anyanwu AC, Banner NR, Mitchell AG, Khaghani A, Yacoub MH. Low incidence and severity of transplant-associated coronary artery disease in heart transplants from live donors. J Heart Lung Transplant. 2003;22(3):281–286. [PubMed]
6. van Der Hoeven JA, Ter Horst GJ, Molema G, de Vos P, Girbes AR, Postema F, Freund RL, Wiersema J, van Schilfgaarde R, Ploeg RJ. Effects of brain death and hemodynamic status on function and immunologic activation of the potential donor liver in the rat. Annals of surgery. 2000;232(6):804–813. [PubMed]
7. Wilhelm MJ, Pratschke J, Laskowski IA, Paz DM, Tilney NL. Brain death and its impact on the donor heart-lessons from animal models. J Heart Lung Transplant. 2000;19(5):414–418. [PubMed]
8. Sebening C, Hagl C, Szabo G, Tochtermann U, Strobel G, Schnabel P, Amann K, Vahl CF, Hagl S. Cardiocirculatory effects of acutely increased intracranial pressure and subsequent brain death. Eur J Cardiothorac Surg. 1995;9(7):360–372. [PubMed]
9. Galinanes M, Hearse DJ. Brain death-induced impairment of cardiac contractile performance can be reversed by explantation and may not preclude the use of hearts for transplantation. Circ Res. 1992;71(5):1213–1219. [PubMed]
10. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. The Journal of clinical investigation. 1997;99(11):2682–2690. [PMC free article] [PubMed]
11. Takada M, Nadeau KC, Hancock WW, Mackenzie HS, Shaw GD, Waaga AM, Chandraker A, Sayegh MH, Tilney NL. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation. 1998;65(12):1533–1542. [PubMed]
12. Pratschke J, Wilhelm MJ, Kusaka M, Laskowski I, Tilney NL. A model of gradual onset brain death for transplant-associated studies in rats. Transplantation. 2000;69(3):427–430. [PubMed]
13. Compagnon P, Wang H, Lindell SL, Ametani MS, Mangino MJ, D'Alessandro AM, Southard JH. Brain death does not affect hepatic allograft function and survival after orthotopic transplantation in a canine model. Transplantation. 2002;73(8):1218–1227. [PubMed]
14. Atkinson C, Zhu H, Qiao F, Varela JC, Yu J, Song H, Kindy MS, Tomlinson S. Complement-dependent P-selectin expression and injury following ischemic stroke. J Immunol. 2006;177(10):7266–7274. [PubMed]
15. Kusaka M, Pratschke J, Wilhelm MJ, Ziai F, Zandi-Nejad K, Mackenzie HS, Hancock WW, Tilney NL. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation. 2000;69(3):405–410. [PubMed]
16. Zhang M, Michael LH, Grosjean SA, Kelly RA, Carroll MC, Entman ML. The role of natural IgM in myocardial ischemia-reperfusion injury. J Mol Cell Cardiol. 2006;41(1):62–67. [PubMed]
17. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, Andersen CB, Angelini A, Berry GJ, Burke MM, Demetris AJ, Hammond E, Itescu S, Marboe CC, McManus B, Reed EF, Reinsmoen NL, Rodriguez ER, Rose AG, Rose M, Suciu-Focia N, Zeevi A, Billingham ME. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24(11):1710–1720. [PubMed]
18. Jassem W, Koo DD, Cerundolo L, Rela M, Heaton ND, Fuggle SV. Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation. 2003;75(12):2001–2007. [PubMed]
19. Gasser M, Waaga AM, Laskowski IA, Tilney NL. The influence of donor brain death on short and long-term outcome of solid organ allografts. Ann Transplant. 2000;5(4):61–67. [PubMed]
20. Gasser M, Waaga AM, Kist-Van Holthe JE, Lenhard SM, Laskowski I, Shaw GD, Hancock WW, Tilney NL. Normalization of brain death-induced injury to rat renal allografts by recombinant soluble P-selectin glycoprotein ligand. J Am Soc Nephrol. 2002;13(7):1937–1945. [PubMed]
21. Shivalkar B, Van Loon J, Wieland W, Tjandra-Maga TB, Borgers M, Plets C, Flameng W. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation. 1993;87(1):230–239. [PubMed]
22. Potapov EV, Wagner FD, Loebe M, Ivanitskaia EA, Muller C, Sodian R, Jonitz B, Hetzer R. Elevated donor cardiac troponin T and procalcitonin indicate two independent mechanisms of early graft failure after heart transplantation. Int J Cardiol. 2003;92(23):163–167. [PubMed]
23. Raisanen-Sokolowski A, Glysing-Jensen T, Russell ME. Donor and recipient contributions of ICAM-1 and P-selectin in parenchymal rejection and graft arteriosclerosis: insights from double knockout mice. J Heart Lung Transplant. 1999;18(8):735–743. [PubMed]
24. Czermak BJ, Friedl HP, Ward PA. Complement, cytokines, and adhesion molecule expression in inflammatory reactions. Proc Assoc Am Physicians. 1998;110(4):306–312. [PubMed]
25. Romano M, Collura M, Lapichino L, Pardo F, Falco A, Chiesa PL, Caimi G, Davi G. Endothelial perturbation in cystic fibrosis. Thromb Haemost. 2001;86(6):1363–1367. [PubMed]
26. Ichikawa H, Flores S, Kvietys PR, Wolf RE, Yoshikawa T, Granger DN, Aw TY. Molecular mechanisms of anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Circ Res. 1997;81(6):922–931. [PubMed]
27. Bone-Larson CL, Simpson KJ, Colletti LM, Lukacs NW, Chen SC, Lira S, Kunkel SL, Hogaboam CM. The role of chemokines in the immunopathology of the liver. Immunological reviews. 2000;177:8–20. [PubMed]
28. Brown K, Sacks SH, Wong W. Extensive and bidirectional transfer of major histocompatibility complex class II molecules between donor and recipient cells in vivo following solid organ transplantation. FASEB J. 2008;22(11):3776–3784. [PubMed]